查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571997

經皮冠狀動脈介入治療 (PCI) 設備的全球市場

Percutaneous Coronary Intervention (PCI) Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，美國經皮冠狀動脈介入治療 (PCI) 設備的全球市場預計將達到 138 億美元

經皮冠狀動脈介入治療(PCI) 設備的全球市場預計到2023 年將達到93 億美元，預計在2023 年至2030 年分析期間將以5.8% 的複合年成長率成長，到2030 年將達到138 億美元。冠狀動脈支架是本報告分析的細分市場之一，複合年成長率為 5.1%，預計到分析期結束時將達到 54 億美元。分析期間 PTCA 導管段的複合年成長率預計為 7.3%。

美國市場預計成長25億美元，中國複合年成長率5.5%

預計 2023 年美國經皮冠狀動脈介入治療 (PCI) 設備市場規模將達到 25 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達22億美元，2023-2030年分析期間複合年成長率為5.5%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 4.9% 和 4.9%。在歐洲，德國的複合年成長率預計為 4.5%。

全球經皮冠狀動脈介入 (PCI) 設備市場 - 主要趨勢和促進因素總結

技術創新將如何改變PCI設備？

由於旨在提高冠狀動脈疾病治療的安全性和有效性的技術創新，經皮冠狀動脈介入治療（PCI）設備市場正在經歷重大轉變。 PCI 是一種用於打開狹窄冠狀動脈的微創手術，依賴多種設備，包括支架、導管和球囊血管成形術。技術的進步促進了藥物釋放型支架 (DES) 的發展，它可以釋放藥物來防止血管再阻塞（動脈血管再阻塞），與裸金屬支架相比，可顯著改善長期預後。此外，隨著時間的推移而溶解的生物可吸收支架也成為一種有前景的選擇，有可能減少長期併發症。其他創新，例如光同調斷層掃瞄(OCT) 和血管內超音波(IVUS) 等血管內成像技術，可實現動脈的精確可視化，從而實現更精確的支架放置並改善手術過程。機器人輔助 PCI 的出現也勢頭強勁，可提高複雜手術過程中的精確度並減少操作員的疲勞。這些技術進步使 PCI 設備更加有效且對患者更友好，從而使其在世界各地的醫療保健系統中得到越來越多的採用。

為什麼 PCI 設備在冠狀動脈疾病的治療中變得至關重要？

由於人口老化、久坐的生活方式以及糖尿病和高血壓的增加等因素，冠狀動脈疾病（CAD）的盛行率不斷增加，對 PCI 設備的需求顯著增加。 PCI 手術為傳統冠狀動脈繞道手術手術 (CABG) 手術提供了一種侵入性較小的替代方案，可縮短恢復時間並降低併發症風險。 PCI 的高成功率，加上支架技術和導管設計的進步，使其成為穩定型心絞痛和心臟病等急性冠狀動脈症候群的首選治療選擇。此外，心導管實驗室的增加和熟練的介入性心臟病專家的數量進一步推動了 PCI 設備的採用。隨著醫療保健提供者致力於改善心血管疾病患者的治療效果，PCI 設備將在CAD 的管理和治療中發揮越來越重要的作用，特別是對於高風險患者或不適合進行心臟直視手術的患者。

監管核准和市場動態如何影響 PCI 設備市場？

監管核准和不斷發展的醫療保健政策正在顯著影響 PCI 設備市場。美國食品藥物管理局(FDA) 和歐洲藥品管理局 (EMA) 等嚴格的監管要求確保 PCI 設備在核准臨床使用之前滿足高安全性和有效性標準。最近核准的新一代藥物釋放型支架和生物可吸收血管支架進一步推動了市場成長，因為這些設備可以改善預後並降低併發症發生率。此外，對基於價值的醫療保健的日益關注正在影響醫院和心臟中心採用 PCI 設備，這不僅可以改善臨床結果，還可以降低長期醫療保健成本。對微創手術的日益重視也為製造商開發和銷售創新 PCI 設備創造了機會。設備製造商和醫療保健提供者之間進行臨床試驗和開發最尖端科技的合作正在加快這個競爭激烈的市場中產品創新的步伐。

推動PCI設備市場成長的因素有哪些？

經皮冠狀動脈介入治療（PCI）設備市場的成長是由技術進步、冠狀動脈疾病盛行率上升以及醫療基礎設施投資增加等多種因素所推動的。關鍵促進因素之一是藥物釋放型支架、生物可吸收支架和改進的導管技術的不斷發展，這些技術大大提高了 PCI 手術的有效性。此外，全球心血管疾病負擔，特別是在老齡化社會以及肥胖和糖尿病發病率不斷上升的地區，導致對微創冠狀動脈介入治療的需求不斷增加。對先進醫療設備的監管支援以及心導管實驗室的增加正在擴大 PCI 手術在已開發市場和新興市場的可用性。此外，向以改善患者治療結果和降低醫療成本為重點的基於價值的醫療模式的轉變正在推動醫院和診所採用先進的 PCI 技術。隨著對冠狀動脈疾病的侵入性較小、更有效的治療方法的需求持續成長，PCI 設備市場預計將持續成長。

全球射孔槍市場－主要趨勢與促進因素總結

科技進步如何影響射孔槍市場？

技術進步在提高油氣井鑽探效率和精確度方面發揮關鍵作用，徹底改變了鑽槍市場。鑽槍是完井過程中使用的關鍵工具，它在井孔和儲層之間創建隧道，使石油和天然氣流入井眼。先進的聚能射孔彈、電子起爆系統和可尋址開關等創新大大提高了鑽井作業的效率和安全性。先進的裝藥幾何形狀可以鑽出更深、更乾淨的孔，提高油井生產率，同時最大限度地減少對地層的損害。此外，電子穿孔系統取代了傳統的機械系統，從而提高了可靠性、精確時間和爆炸過程的即時控制。這些系統降低了意外爆炸的風險，並允許在一次操作中鑽多個區域，從而最佳化操作效率。此外，槍枝設計的創新，包括模組化和可重複使用的鑽槍，正在降低營運成本並提高完井的環境永續性。這些進步正在推動穿孔槍在陸上和海上鑽井作業的採用。

為什麼穿孔槍在石油和天然氣產業很重要？

射孔槍在石油和天然氣工業中發揮重要作用，可以有效地從儲存中提取碳氫化合物。鑽完井眼後，用鑽槍穿透套管和水泥，形成一條將井孔與油氣儲存連接起來的溝槽。這個過程對於促進碳氫化合物流動和最大限度地提高油井產能至關重要。穿孔槍的多功能性使其對於傳統和非常規鑽井作業（包括頁岩地層中的水力壓裂）至關重要。對於鑽井條件更為嚴苛的海上作業，專為高壓高溫 (HPHT) 環境設計的穿孔槍可確保可靠的性能和安全性。隨著全球對石油和天然氣的需求不斷增加，特別是在新興經濟體，對高效且具有成本效益的鑽井技術（例如先進的穿孔槍）的需求也在增加。穿孔槍不僅對於最佳化生產至關重要，而且在減少停機時間和提高油井作業的整體經濟效益方面也發揮關鍵作用。

產業趨勢與環境因素如何影響穿孔槍市場？

行業趨勢，特別是對成本效率和環境永續性的日益關注，正在塑造穿孔槍市場的未來。石油和天然氣公司擴大尋求穿孔技術，以提高油井生產率，同時減少對環境的影響。因此，對可重複使用的模組化鑽槍的需求不斷成長，這些鑽槍可以多次部署，減少廢棄物並降低營運成本。此外，高性能定形炸藥的進步最大限度地減少了鑽井過程中炸藥的使用量，有助於減少完井時的環境足跡。石油和天然氣作業向數位化和自動化的轉變也正在影響市場，電子雷管系統由於其準確性、可靠性以及與其他地下技術整合的能力而變得越來越受歡迎。此外，水平鑽井和水力壓裂等非常規鑽井技術的日益採用，增加了對能夠處理複雜井幾何形狀和高壓的先進鑽井系統的需求。隨著環境法規變得更加嚴格，業界對永續和高效鑽井解決方案的關注將繼續成長。

推動射孔槍市場成長的因素有哪些？

鑽槍市場的成長受到多種因素的推動，例如技術進步、全球石油和天然氣需求的增加以及非常規鑽井作業的擴張。主要驅動力之一是先進鑽井技術的發展，以提高油井產能和作業效率。越來越多採用電子起爆系統和可重複使用的鑽槍也有助於市場成長，因為這些技術降低了成本並提高了完井過程中的安全性。此外，世界各地向非常規鑽井方法（例如頁岩地層中的水力壓裂）的轉變，正在推動對能夠應對複雜井眼環境的高性能穿孔槍的需求。對環境永續性的日益關注以及遵守更嚴格法規的需求促使石油和天然氣公司採用穿孔系統，以最大限度地提高資源開採率，同時最大限度地減少對環境的影響。隨著能源產業的不斷發展，在這些技術、環境和營運趨勢的推動下，穿孔槍市場預計將擴大。

受訪企業範例（44家知名企業）

  • Abbott Laboratories
  • AMG International
  • Asahi Intecc Co., Ltd.
  • B. Braun Melsungen AG
  • Biosensors International Group Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • BrosMed Medical Co., Ltd.
  • Claret Medical
  • Comed BV
  • Contego Medical, LLC
  • Cordis Corporation
  • Elixir Medical Corporation
  • EPflex Feinwerktechnik GmbH
  • GaltNeedleTech
  • Lepu Mdicial Technology（Beijing）Co., Ltd
  • Medtronic PLC
  • Meril Life Sciences Pvt., Ltd.
  • Merit Medical Systems, Inc.
  • OptiMed Medizinische Instrumente GmbH
  • OrbusNeich
  • Penumbra, Inc.
  • RONTIS
  • SP Medical A/S
  • Stentys SA
  • Teleflex Inc.
  • Terumo Medical Corporation

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP13911

Global Percutaneous Coronary Intervention (PCI) Devices Market to Reach US$13.8 Billion by 2030

The global market for Percutaneous Coronary Intervention (PCI) Devices estimated at US$9.3 Billion in the year 2023, is expected to reach US$13.8 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Coronary Stents, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$5.4 Billion by the end of the analysis period. Growth in the PTCA Catheters segment is estimated at 7.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.5 Billion While China is Forecast to Grow at 5.5% CAGR

The Percutaneous Coronary Intervention (PCI) Devices market in the U.S. is estimated at US$2.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 5.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.9% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Percutaneous Coronary Intervention (PCI) Devices Market – Key Trends & Drivers Summarized

How Are Technological Innovations Transforming PCI Devices?

The percutaneous coronary intervention (PCI) devices market has undergone remarkable transformation, driven by technological innovations aimed at improving the safety and efficacy of coronary artery disease treatments. PCI, a minimally invasive procedure used to open narrowed coronary arteries, relies on a variety of devices such as stents, catheters, and balloon angioplasty. Technological advancements have led to the development of drug-eluting stents (DES), which release medication to prevent restenosis (re-narrowing of the arteries), significantly improving long-term outcomes compared to bare-metal stents. Additionally, bioresorbable stents, which dissolve over time, are emerging as a promising alternative, offering the potential to reduce long-term complications. Other innovations, such as intravascular imaging technologies like optical coherence tomography (OCT) and intravascular ultrasound (IVUS), allow for precise visualization of the arteries, enabling more accurate stent placement and reducing procedural risks. The advent of robotics-assisted PCI is also gaining momentum, offering enhanced precision and reduced operator fatigue during complex procedures. These technological advancements are making PCI devices more effective and patient-friendly, thereby driving adoption across healthcare systems globally.

Why Are PCI Devices Becoming Crucial in the Treatment of Coronary Artery Disease?

The growing prevalence of coronary artery disease (CAD), driven by factors such as aging populations, sedentary lifestyles, and rising incidences of diabetes and hypertension, has significantly increased the demand for PCI devices. PCI procedures offer a less invasive alternative to traditional coronary artery bypass graft (CABG) surgery, reducing recovery times and lowering the risk of complications. The high success rates of PCI, coupled with advancements in stent technology and catheter design, have made it a preferred treatment option for both stable angina and acute coronary syndromes like heart attacks. Furthermore, the increasing number of cardiac catheterization labs and the rise in skilled interventional cardiologists worldwide are further boosting the adoption of PCI devices. As healthcare providers focus on improving outcomes for patients with cardiovascular diseases, PCI devices are playing an increasingly critical role in managing and treating CAD, particularly in patients who are high-risk or not ideal candidates for open-heart surgery.

How Are Regulatory Approvals and Market Dynamics Influencing the PCI Devices Market?

Regulatory approvals and evolving healthcare policies are significantly shaping the PCI devices market. Stringent regulatory requirements from agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) ensure that PCI devices meet high standards for safety and efficacy before they are approved for clinical use. Recent approvals of newer-generation drug-eluting stents and bioresorbable vascular scaffolds are further driving market growth, as these devices offer improved outcomes and reduced complication rates. In addition, the rising focus on value-based healthcare is influencing hospitals and cardiology centers to adopt PCI devices that not only improve clinical outcomes but also reduce long-term healthcare costs. The growing emphasis on minimally invasive procedures is also creating opportunities for manufacturers to develop and market innovative PCI devices. Collaborations between device manufacturers and healthcare providers, aimed at conducting clinical trials and developing cutting-edge technologies, are accelerating the pace of product innovation in this competitive market.

What Factors Are Driving Growth in the PCI Devices Market?

The growth in the percutaneous coronary intervention (PCI) devices market is driven by several factors, including technological advancements, the rising prevalence of coronary artery disease, and increasing healthcare infrastructure investments. One of the primary drivers is the ongoing development of drug-eluting stents, bioresorbable stents, and improved catheter technologies, which are significantly enhancing the effectiveness of PCI procedures. Additionally, the global burden of cardiovascular diseases, particularly in aging populations and regions with increasing rates of obesity and diabetes, is leading to higher demand for minimally invasive coronary interventions. Regulatory support for advanced medical devices, along with the growing number of cardiac catheterization labs, is expanding the accessibility of PCI procedures in both developed and emerging markets. Moreover, the shift toward value-based healthcare models, which focus on improving patient outcomes and reducing healthcare costs, is prompting hospitals and clinics to adopt advanced PCI technologies. As the demand for less invasive, more effective treatments for coronary artery disease continues to rise, the PCI devices market is expected to experience sustained growth.

Global Perforating Guns Market – Key Trends & Drivers Summarized

How Are Technological Advancements Impacting the Perforating Guns Market?

Technological advancements are playing a crucial role in revolutionizing the perforating guns market, making oil and gas well perforation more efficient and precise. Perforating guns, essential tools used in well-completion processes, create tunnels between the wellbore and the reservoir, allowing oil or gas to flow into the well. Innovations such as advanced-shaped charges, electronic detonation systems, and addressable switches have significantly improved the efficiency and safety of perforation operations. Advanced-shaped charges are now capable of producing deeper and cleaner perforations, enhancing well productivity while minimizing formation damage. Additionally, electronic perforating systems have replaced traditional mechanical ones, offering improved reliability, precise timing, and real-time control over the detonation process. These systems reduce the risk of misfires and allow for multi-zone perforation in a single run, optimizing operational efficiency. Moreover, innovations in gun design, including modular and reusable perforating guns, are lowering operational costs and increasing the environmental sustainability of well completions. These advancements are driving greater adoption of perforating guns in both onshore and offshore drilling operations.

Why Are Perforating Guns Critical in the Oil and Gas Industry?

Perforating guns play a critical role in the oil and gas industry by enabling the efficient extraction of hydrocarbons from reservoirs. After a well has been drilled, perforating guns are used to penetrate the casing and cement to create channels that connect the wellbore to the oil or gas reservoir. This process is vital for enhancing the flow of hydrocarbons and maximizing well productivity. The versatility of perforating guns makes them indispensable for both conventional and unconventional drilling operations, including hydraulic fracturing (fracking) in shale formations. In offshore operations, where drilling conditions are more challenging, perforating guns designed for high-pressure, high-temperature (HPHT) environments ensure reliable performance and safety. As global demand for oil and gas continues to rise, particularly in emerging economies, the need for efficient and cost-effective well-completion technologies, such as advanced perforating guns, is also increasing. Perforating guns are not only essential for optimizing production but also play a key role in reducing downtime and improving the overall economics of well operations.

How Are Industry Trends and Environmental Considerations Shaping the Perforating Guns Market?

Industry trends, particularly the growing focus on cost-efficiency and environmental sustainability, are shaping the future of the perforating guns market. Oil and gas companies are increasingly seeking perforating technologies that enhance well productivity while reducing environmental impact. As a result, there is growing demand for reusable and modular perforating guns that can be deployed multiple times, reducing waste and lowering operational costs. Additionally, advancements in high-performance shaped charges are minimizing the amount of explosives used during perforation, which helps reduce the environmental footprint of well completions. The shift toward digitalization and automation in oil and gas operations is also influencing the market, with electronic detonation systems becoming more popular due to their precision, reliability, and ability to integrate with other downhole technologies. Furthermore, the rising adoption of unconventional drilling techniques, such as horizontal drilling and fracking, is driving demand for advanced perforating systems that can handle complex well geometries and high pressures. As environmental regulations become stricter, the industry’s focus on sustainable and efficient perforating solutions will continue to grow.

What Factors Are Driving Growth in the Perforating Guns Market?

The growth in the perforating guns market is driven by several factors, including technological advancements, increasing global demand for oil and gas, and the expansion of unconventional drilling operations. One of the main drivers is the development of advanced perforating technologies that improve well productivity and operational efficiency. The rising adoption of electronic detonation systems and reusable perforating guns is also contributing to market growth, as these technologies reduce costs and improve safety during well completions. Additionally, the global shift toward unconventional drilling methods, such as hydraulic fracturing in shale formations, is fueling demand for high-performance perforating guns capable of handling complex well environments. The growing focus on environmental sustainability and the need to comply with stricter regulations are prompting oil and gas companies to invest in perforating systems that minimize environmental impact while maximizing resource extraction. As the energy industry continues to evolve, the perforating guns market is expected to expand, driven by these technological, environmental, and operational trends.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • AMG International
  • Asahi Intecc Co., Ltd.
  • B. Braun Melsungen AG
  • Biosensors International Group Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • BrosMed Medical Co., Ltd.
  • Claret Medical
  • Comed B.V.
  • Contego Medical, LLC
  • Cordis Corporation
  • Elixir Medical Corporation
  • EPflex Feinwerktechnik GmbH
  • GaltNeedleTech
  • Lepu Mdicial Technology (Beijing) Co., Ltd
  • Medtronic PLC
  • Meril Life Sciences Pvt., Ltd.
  • Merit Medical Systems, Inc.
  • OptiMed Medizinische Instrumente GmbH
  • OrbusNeich
  • Penumbra, Inc.
  • RONTIS
  • SP Medical A/S
  • Stentys SA
  • Teleflex Inc.
  • Terumo Medical Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Percutaneous Coronary Intervention (PCI) Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases (CVD) Drives Growth in Percutaneous Coronary Intervention (PCI) Devices Market
    • Technological Advancements in Drug-Eluting Stents (DES) Improve Long-Term Outcomes and Spur Market Growth
    • Increasing Adoption of Minimally Invasive Procedures Propels Demand for PCI Devices in Cardiac Interventions
    • Rising Use of Bioresorbable Stents Expands Market for Innovative, Temporary PCI Devices
    • Technological Innovations in Intravascular Imaging Systems (OCT and IVUS) Enhance Precision in PCI Procedures
    • Growing Focus on Robotic-Assisted PCI Systems Strengthens the Business Case for High-Precision Cardiac Interventions
    • Increased Demand for Next-Generation Balloon Catheters Expands Market for Advanced PCI Tools
    • Rising Adoption of PCI Devices in Treating Acute Coronary Syndromes (ACS) Expands Clinical Applications
    • Technological Advancements in Antithrombotic Devices and Drug-Coated Balloons Improve PCI Outcomes
    • Growing Focus on Outpatient and Ambulatory PCI Procedures Expands Market for Less Invasive Cardiac Devices
    • Rising Geriatric Population and High Prevalence of Coronary Artery Disease (CAD) Drive PCI Market Growth
    • Growing Emphasis on Personalized and Precision Medicine Fuels Development of Customized PCI Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Percutaneous Coronary Intervention (PCI) Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Coronary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for PTCA Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for PTCA Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for PTCA Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Catheterization Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Catheterization Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Catheterization Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
  • JAPAN
    • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
  • CHINA
    • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
  • EUROPE
    • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
  • FRANCE
    • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
  • GERMANY
    • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030

IV. COMPETITION